patent/TW-200621735-A

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42e94091a4fc81b8d0237117707cc7ee
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D265-18
filingDate	2005-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e074dd8a79936adc52e9f4e21a1daee0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9edd7c8b76c3e22650d8d04e1791707 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5764cc2df269be445d44b1227768be5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66087cd4bcf600813a3aa73d7e2f1c1f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b4062803d330941a0dac95ffd1b1f12b
publicationDate	2006-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	TW-200621735-A
titleOfInvention	Synthesis of a benzoxazinone
abstract	The present invention provides novel methods for the synthesis of (S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one of formula (III) which is useful as a human immunodeficiency virus (HIV) reverse transcriptase inhibitor.
priorityDate	2004-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID12721 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID64139 http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID12721 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID422138360 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19937448 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535515

Total number of triples: 20.